[EN] AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES<br/>[FR] INHIBITEURS DE KINASES ASSOCIÉES AUX RÉCEPTEURS D'INTERLEUKINE À BASE D'AMIDOPYRAZOLE
申请人:MERCK SHARP & DOHME
公开号:WO2012129258A1
公开(公告)日:2012-09-27
This invention relates to amidopyrazole compounds that are inhibitors of Interleukin receptor-associated kinases, in particular IRAK-4, and are useful in the treatment of cellular proliferative diseases, for example, cancer, hyperplasia, restenosis, cardiac hypertrophy, immune disorders and inflammation.
这项发明涉及抗干扰素受体相关激酶(特别是IRAK-4)的抑制剂——amidopyrazole化合物,可用于治疗细胞增殖性疾病,例如癌症、增生、再狭窄、心肌肥大、免疫紊乱和炎症。